Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
about
Pharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory ActivityOnce daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.Sustainable Synthesis of Balsalazide and Sulfasalazine Based on Diazotization with Low Concentrations of Nitrogen Dioxide in Air.
P2860
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@ast
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@en
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@nl
type
label
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@ast
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@en
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@nl
prefLabel
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@ast
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@en
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@nl
P2860
P3181
P356
P1476
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
@en
P2093
Daniel R van Langenberg
P2860
P304
P3181
P356
10.4292/WJGPT.V6.I4.137
P407
P577
2015-11-06T00:00:00Z